-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Assumes Nanobiotix at Buy, Announces Price Target of $64

Benzinga·09/15/2026 13:17:20
语音播报
Guggenheim analyst Paul Jeng assumes Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $64.